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This study was undertaken to determine whether cell cooperation, either among
monocytes or between monocytes and lymphocytes, is a prerequisite for mono-
cyte chemotactic responsiveness. We compared Ficoll-Hypaque-separated mono-
nuclear cells and a preparation of 99% pure monocytes obtained by chemotaxis in
a newly designed separation chamber. Monocytes of both preparations migrated
to chemoattractants without a lag phase, and no further increase in migrated cells
was observed after 70 min. The cell dose-response was linear for both prepara-
tions over a wide range of cell concentrations in the cell input well of the
chemotaxis chamber, suggesting that no monocyte-monocyte interaction was
required. Since only 20 to 60% of the monocytes purified by chemotaxis migrated
a second time, the possibility of a requirement for an accessory cell was tested.
The addition to purified monocytes of several different mononuclear cell prepara-
tions comprising lymphocytes or nonmigrating monocytes had no effect on
monocyte migration. These experiments show that normal human blood mono-
cytes in vitro do not require stimuli from other cells to respond to chemoattrac-
tants. Their behavior is profoundly different from that of mouse peritoneal
macrophages, which exhibit a time lag in vitro before migration toward an
attractant and become more responsive with either increasing cell concentration
or addition of purified lymphocytes.
Macrophages play an important role in the
immunological response as both amplifying cells
and effector cells. Peripheral blood monocytes
are precursors of these macrophages, and their
ability to migrate may be essential for accumula-
tion at inflammation sites. Monocytes from pa-
tients with a variety of diseases, including can-
cer, exhibit abnormal chemotaxis in vitro.
Although the nature of monocyte chemotaxis
defects in disease is still unknown, the literature
suggests several interesting possibilities: (i) cir-
culating serum inhibitors of chemotaxis, (ii) spe-
cific deactivation, and (iii) requirement for an
accessory cell. Investigators have found inhibi-
tors of chemotaxis in serum (for review, see
reference 20) or have isolated inhibitors of che-
motaxis released by neoplastic cells (15, 17, 18).
The possibility of specific deactivation in dis-
ease was suggested by the finding that only 50%
of the patients with a reduced response to lym-
phocyte-derived chemotactic factor also had im-
paired responses to endotoxin-activated serum
(3). In studies on normal human monocytes, we
showed that the cells capable of migrating into a
chemotactic gradient are a subpopulation com-
prising 20 to 40% of the total blood monocytes
(8). They carry multiple chemotaxin specificities
on their surfaces, as shown by the fact that a
suppressed response can be induced by high
concentrations of one chemoattractant without
alteration of responses to a different attractant
(9). Thus, receptor-specific inhibition of mono-
cyte chemotaxis can be demonstrated in vitro.
The possibility of an accessory cell affecting
monocyte chemotactic responsiveness is usually
not considered, and it has been shown that, over
a wide range of lymphocyte-monocyte ratios,
chemotaxis depended only on the number of
monocytes (2, 8, 19). However, Norris et al.
showed that the depressed monocyte response
of patients with mycosis fungoides was partially
restored by lymphocytes. Furthermore, we re-
ported that the chemotactic responsiveness of
mouse macrophages is increased by the addition
of autologous lymphocytes (13), and evidence
for cell-cell interaction in the chemotactic re-
sponse has been obtained for both mouse perito-
neal macrophages (13) and cell lines (1). These
findings stimulated us to determine whether
there is any evidence for cell-cell interaction in
the chemotactic responses of normal human
monocytes. The methods included analysis of
the time course of the chemotactic response and
development of a new technique for obtaining
suspensions of pure monocytes to which other
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MATERIALS AND METHODS
Cell preparation. Blood was drawn from healthy
donors and heparinized. After isolation of mononucle-
ar cells by the method of Boyum (6), the interface cell
layer was removed and washed twice with Gey bal-
anced salt solution containing 2% bovine serum albu-
min, Cohn fraction V (Gey-BSA; National Institutes of
Health Media Unit, Bethesda, Md.). The cell suspen-
sion contained 15 to 35% monocytes, 65 to 85%
lymphocytes, and less than 1% granulocytes. Viability
was better than 99% as measured by trypan blue dye
exclusion. Total and differential counts were made for
the final washed preparations. Total leucocyte recov-
ery was 1 x 106 to 3 x 106 cells per ml of whole blood.
Differential counts were made after staining cell sus-
pensions with euchrysin 3RX (Roboz Surgical Instru-
ment Co., Inc., Washington, D.C.). To 50 ,ul of the cell
suspension with a monocyte concentration of about 2
x 101 /ml, 10 ,u of a euchrysin solution in phosphate-
buffered saline (PBS; 0.3 mg/ml) was added, and the
mixture was incubated at room temperature for about
5 min. Ten microliters was placed on a microscope
slide, a cover slip was added, and the cells were
observed with a fluorescence microscope. Monocytes
were distinguished by bright red cytoplasmic fluores-
cence, and the numbers thus determined were used to
standardize the monocyte number added per well. The
results of this method correlated closely with the
counting of monocytes by other criteria: (i) morpholo-
gy as determined on cytocentrifuged preparations
stained with Diff-Quick (Harleco, Philadelphia, Pa.);
(ii) peroxidase staining; and (iii) phagocytosis of sheep
erythrocytes sensitized with immunoglobulin G anti-
Forsmann antibody, 90 to 95% of the monocytes, by
morphological criteria, ingesting erythrocytes. Percoll
(Pharmacia Fine Chemicals, Inc., Piscataway, N.J.)
was also used to isolate monocytes as described by
Pertoff et al. (16). Briefly, an isotonic stock solution of
Percoll in PBS was prepared with a density of 1.024 at
22°C, measured with density marker beads (Pharmacia
Fine Chemicals, Inc.). Ficoll-Hypaque-separated
mononuclear cells at a concentration of 2 x 106 to 10 x
106 cells per ml in 7 ml of PBS were underlayered with
3 ml of Percoll stock solution diluted 1:1 with PBS.
After centrifugation for 60 min at 800 x g, the cell
band on the Percoll cushion was removed with a
pipette. The cells were washed once with Gey-BSA.
The purity of this cell suspension was between 84 and
94% as determined by morphological and phagocytic
criteria. The contaminating cells were lymphocytes.
The monocyte yield in the band was between 30 and
70%. Suspensions enriched for lymphocytes were pre-
pared in two ways. Cells were incubated in a petri dish
for 1 h at 37°C in moist air. The dish was then gently
shaken, and the nonattached cells were poured off and
washed once in medium. The remaining monocyte
contamination was about 2%. In other assays, the
mononuclear cell suspension was diluted to 2 x 106
cells per ml in Gey-BSA, and a carrageenan (Sea Kem
9; Marine Colloids, Rockland, Maine) stock solution
was added to a final concentration of 50 pug/ml to cause
destruction of monocytes (12). This suspension was
incubated for 2.5 h with frequent mixing; the cells
were then centrifuged, washed twice in medium, and
then suspended in the appropiate volume of Gey-BSA.
The purity of the lymphocytes was 98%.
Chemotaxis assay. Chemotaxis was assayed in a
multiwell chamber as described previously (7). Bottom
wells were filled with 25 ,ul of attractant solutions in
Gey-BSA. A Nuclepore filter sheet (Polyvinylpyrroli-
done coated, 10 ,um thick, 5 ,um hole size; Neuro
Probe Inc., Bethesda, Md.) was placed over the wells,
providing a surface area of 8 mm2 per well. Gasket and
top plate were assembled, and 50 p.J of cell suspension
containing 40,000 to 100,000 monocytes, depending on
the experiment, were added to each top well. Cham-
bers were incubated for 90 min in moist air containing
5% carbon dioxide. After incubation, chambers were
disassembled and filters were removed. Cells remain-
ing on the top side were wiped off, and filters were
immersed in methanol for 15 s and then stained in Diff-
Quick (Harleco). The number of cells per square
millimeter (between 1,000 and 3,000) was counted with
an image analyzer. With optimal concentrations of N-
formylmethionyl-leucyl-phenylalanine or C5a, 20 to
40% of the monocytes migrated toward attractant,
depending on the donor (8). Assay points were in
triplicate, and the standard error of the mean was not
greater than 15%.
Chemotactic factors. N-Formylmethionyl-leucyl-
phenylalanine was purchased from Sigma Chemical
Co., St. Louis, Mo. Stock solutions (10-3 M) were
prepared in either ethanol or dimethylsulfoxide and
stored at -20°C. Human serum-derived complement
component CSa was prepared by a modified procedure
of Fernandez and Hugli (10) as described previously
(8). Briefly, fresh serum was incubated with zymosan
(Mann Research Laboratories, New York, N.Y.) in the
presence of epsilon-aminocaproic acid (Sigma Chem-
ical Co.). CSa was then purified by consecutive chro-
matography on CM Sepharose Cl 6B (Pharmacia Fine
Chemicals, Inc.) and Sephadex G-100. The final prepa-
ration was stored as a solution in PBS at -20°C.
Lymphocyte-derived chemotactic factor was prepared
as described previously (8). N-Formyl-norleucyl-leu-
cyl-phenylalanine (FNLP) was a generous gift from
Elliot Schiffmann.
Cell separation by chemotaxis. To separate migrating
from nonmigrating monocytes, a newly constructed
separation chamber was used (Neuro Probe Inc.). As
in our 48-well chamber (7), upper and lower compart-
ments were separated by a Nuclepore membrane filter
(25 by 80 mm), but the area was divided into only four
big compartments. The total filter area available for
chemotaxis was 1,350 mm2 (equal to the filter area of
170 wells of the multiwell chamber). The volumes of
each of the four bottom and top compartments were
1.3 and 2.0 ml, respectively. The bottom wells were
filled with attractant solution; the top wells were filled
with a cell suspension containing not more than 2 x
106 monocytes per ml. The chamber was then incubat-
ed for 90 min at 37°C in moist air containing 5% CO2.
After incubation, the cells on the top of the filter were
collected by rinsing with a pipette. The filter top was
then wiped with a cotton swab to eliminate residual
cells. The filter was removed and clamped to the inside
of a 250-ml polypropylene tube with its neck cut off
(no. 25350; Corning Glass Works, Corning, N.Y.), cell
side exposed. The migrated cells were rinsed off with
medium, washed once to remove traces of chemotac-
tic factor, and counted. The purity of the migrated
monocytes was better than 99%. The yield was 20 to
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to 40%o of the input monocytes can migrate. The total
cell yield (top and bottom cells) was between 75 and
90o, depending on the experiment. No trypan blue-
positive cells were found.
RESULTS
Cell separation by chemotaxis. To determine
whether other leukocytes affected monocyte
chemotaxis, it was necessary to obtain pure
monocytes. Previously, no methods were avail-
able to prepare pure monocyte suspensions suit-
able for chemotaxis experiments. In these stud-
ies, we designed a separation chamber (see
Materials and Methods) to obtain purified mono-
cytes by chemotaxis. This method was based on
the fact that, with Ficoll-Hypaque-separated
cells (comprising monocytes, lymphocytes, and
approximately 0.5% neutrophils), the cells mi-
grating toward attractant through the pores of a
Nuclepore filter were exclusively monocytes.
The few neutrophils that migrated fell off the
polyvinylpyrrolidone-coated filters (11). Thus,
after 90 min of incubation, the attractant side of
the filter was covered with monocytes which
were rinsed off relatively easily. No residual
cytoplasmic material was seen on the filter after
staining. No trypan blue-positive cells were
seen, and no gross morphological changes were
detected. Typically, 20 to 40% of the input
monocytes were recovered from the filter bot-
tom. This percentage corresponds to that of
migration in normal individuals in vitro (8). The
attractants used for these separations were
FNLP at a concentration of 2 x 10-7 M and C5a
at a dilution of 1:500. Both concentrations were
optimal for chemotaxis, and the effects of specif-
ic deactivation under these conditions were
small (10 to 15%).
Time course of chemotaxis. To determine
whether the removal of lymphocytes had any
effect on the time course of monocyte chemotax-
is, Ficoll-Hypaque-separated mononuclear cells
(approximately 75% lymphocytes and 25%
monocytes) and monocytes purified by chemo-
taxis were compared. One multiwell chamber
was set up for each time point. All chambers
were put in the incubator at time zero. At the
times indicated in Fig. 1 and 2, chambers were
removed and migrated cells were counted. As
shown in the figures, chemotaxis was complete
in both cases after 70 min, and the shapes of the
curves were essentially the same. Extrapolation
of the curves shows that they intersect the
abscissa at about 10 min. Thus, the cells exhibit-
ed no time lag before migrating, considering that
they needed approximately 5 to 10 min to sedi-
ment to the filter surface. The absence of a lag
phase suggests that little or no preparatory time
was necessary, in contrast to mouse macro-
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FIG. 1. Time course of chemotaxis of Ficoll-Hypa-
que-separated human monocytes. Cells were prepared
as described in the text. One multiwell chamber was
set up for each time point. Monocyte input number
was 50,000 per well. All chambers were started at time
0 and removed from the incubator at the indicated
times. The filters were immediately prepared for
counting. The numbers represent the mean of tripli-
cate determinations. Symbols: 0, C5a (1:800 dilution
of stock); 0, lymphocyte-derived chemotactic factor
(1:10 dilution); A, FNLP (2 x 10-7 M).
was the same for each of the three attractants.
We have shown previously that, although the
different attractants interact with functionally

















FIG. 2. Time course of chemotaxis of migrated
monocytes. Migrated monocytes were separated from
Ficoll-Hypaque cells in a separation chamber with 2 x
10-7 M FNLP used as attractant in the bottom com-
partment. After incubation, the cells were recovered
from the attractant side of the filter and used as
migrated monocytes. The assay was done as described
in the legend to Fig. 1. Monocyte input number was
50,000 per well. 0, Lymphocyte-derived chemotactic
factor (1:10 dilution); 0, C5a (1:800 dilution); A,
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sponds to each attractant. The concentrations
used in the figures were optimal. In other
experiments with suboptimal concentrations,
the curve shape was similar, except for a lower
plateau after 70 min.
Dependence of chemotaxis on cell density. If
cell cooperation either between different cells or
among the monocytes themselves was a prereq-
uisite for chemotaxis, the percentage of input
cells that migrate should increase over a certain
range of increasing cell input number, as we
have shown for mouse peritoneal macrophages
(13) and cell lines (1). On the other hand, our
published cell dose-response curves for Ficoll-
Hypaque-separated unpurified human mononu-
clear cells were linear over a wide range, show-
ing that the percentage of input monocytes
migrating was constant (7, 8). Therefore, in the
case of human monocytes, either no cell cooper-
ation occurs or the accessory cell is present in
excess over the entire range of the cell dose-
response. The cell dose-response curve was also
linear for monocytes purified by chemotaxis
(Fig. 3). This was true for all attractants used
and for monocytes purified on Percoll. The log-
log plot lines have a slope of 1.0, indicating that
the fraction of cells migrating was independent
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FIG. 3. Cell dose-response of migrated monocytes.
Migrated monocytes were prepared as described in the
legend to Fig. 2. A log 2 dilution series of the cells in
Gey-BSA was prepared, and chemotaxis was mea-
sured in multiweli chambers in duplicate. The reagents
in bottom wells were: lymphocyte-derived chemotac-
tic factor, 1:10 (A); FNLP, 2 x 10-7M (0); C5a, 1:800
(0); Gey-BSA (O).
monocyte-monocyte interaction occurred over
the observed range. If an accessory cell had
been removed during purification, the cell dose-
response should still be linear, but the percent-
age migrating would be less. In fact, only 20 to
60% of the chemotaxis-purified monocytes mi-
grated to attractant, despite the fact that 100% of
them had migrated in the purification procedure.
Less than 100% migration was not due to specif-
ic deactivation, since similar responses were
seen for three unrelated attractants. Further-
more, in separate deactivation experiments, lit-
tle or no specific deactivation was observed with
attractant concentrations used for monocyte
separation, i.e., 2 x 10-7 M FNLP or 1:500 C5a.
Other causes for suboptimal migration of sepa-
rated monocytes could be an intrinsic decline in
the functional capacity of the monocytes or the
removal of an accessory cell. The latter possibil-
ity was evaluated as described below by deter-
mining whether the addition of various cell pop-
ulations to the purified monocytes increased
their chemotactic responsiveness.
Recombination experiments. To determine
whether lymphocytes or nonmigrating mono-
cytes affected monocyte chemotactic responses,
we prepared the following cell suspensions.
Cells recovered from the top of a separation
chamber filter after all of the chemotactically
responsive monocytes had migrated to the bot-
tom of the filter were used in three different
ways: (i) untreated, comprising lymphocytes
and nonmigrating monocytes; (ii) treated by
adherence to plastic, the nonadherent cells com-
prising lymphocytes and residual (approximate-
ly 4%) monocytes; and (iii) treated with carra-
geenan, which destroyed monocytes but did not
affect lymphocytes (12). These cells included
plastic adherent lymphocytes that were not pres-
ent in the second preparation. To a constant
number of purified monocytes, increasing num-
bers of these cell fractions were added, and the
suspensions were incubated for 10 min before
they were pipetted into the chemotaxis wells.
The nonadherent cell fraction neither enhanced
nor suppressed chemotaxis (Table 1). To test the
possibility that adherent lymphocytes could af-
fect monocyte chemotaxis, cells from the top of
the separation chamber were treated with carra-
geenan for 2.5 h to destroy nonmigrated mono-
cytes. Only 2% of the monocytes remained
intact. Lymphocytes were not damaged, as de-
termined by their response to three different
mitogens. [3H]thymidine uptake after the addi-
tion of concanavalin A, phytohemagglutinin, or
lipopolysaccharide was 160, 130, and 80%, re-
spectively, of the response by mononuclear cells
not treated with carrageenan. A recombination
assay identical to that shown in Table 1 was
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TABLE 1. Effect of nonadherent cells on
chemotaxis of monocytes purified by chemotaxisa
No. of Chemotactic response toc:
nonadherent
celis per wellb Medium FNLP C5a
0 256 ± 12 1,960 ± 175 2,290 ± 285
5,000 224 ± 17 1,980 ± 190 2,315 ± 150
10,000 317 ± 25 2,050 ± 130 2,260 ± 210
20,000 202 ± 10 1,850 ± 45 2,370 ± 280
40,000 230 ± 25 2,230 ± 280 2,400 ± 125
80,000 270 ± 45 1,770 ± 210 2,530 ± 70
a Migrating monocytes were separated from the
Ficoll-Hypaque mononuclear cell mixture by chemo-
taxis to C5a. The effect of nonadherent cells on the
chemotactic response of the separated monocytes was
determined in a multiwell chamber by adding 40,000
separated monocytes per well plus nonadherent cells
as indicated.
b Cells that were recovered from the top well of a
separation chamber after chemotaxis were incubated
for 30 min in a culture dish in Gey-BSA. Nonadherent
cells were then poured off, counted, and used. Cells
were mixed, preincubated for 10 min, and then as-
sayed.
c Number of cells migrated per square millimeter of
filter ± standard error of the mean. FNLP and CSa
were used at concentrations of 2 x 10-7 and 1:500,
respectively.
In a third type of recombination assay, cells that
were recovered from the top of the separation
chamber filter were added back to the migrated
cells without any further treatment. There was
no effect on monocyte migration (Table 3). Oth-
er recombination experiments were carried out
at lower monocyte densities (20,000 per well)
and higher densities (80,000 per well). An effect
of added lymphocytes was not seen. These
experiments show that there is no accessory cell
in the nonmigrated population that enhances
monocyte responsiveness.
All of the above experiments were also done
with monocytes separated on a Percoll cushion
(16). The highest purity we achieved was 94% at
a rather low yield (30%). The results of adding
lymphocytes (in the form of carrageenan-treated
cells or nonadherent cells) to this preparation
were comparable to those shown in Tables 1 and
2.
DISCUSSION
The experiments reported in this paper were
designed as a result of our finding that accessory
cells play a role in the chemotaxis of mouse
macrophages in vitro. For both mouse resident
peritoneal macrophages (13) and mouse macro-
phage-like cell lines (1), the percentage of cells
that migrated increased with cell density. Fur-
thermore, addition of lymphocytes to a constant
number of mouse peritoneal cells in the chemo-
TABLE 2. Effect of lymphocytes on chemotaxis of
monocytes purified by chemotaxisa
No. of Chemotactic response toc:
lymphocytes
per wellb Medium FMLP C5a
0 156 ± 13 2,075 ± 50 2,360 ± 390
5,000 140 ± 20 1,890 ± 100 2,360 ± 340
20,000 135 ± 5 1,890 ± 60 2,140 ± 185
80,000 150 ± 5 2,170 ± 160 2,260 ± 210
a Migrating monocytes were separated by chemo-
taxis to C5a. The effect of lymphocytes on the chemo-
tactic response of the separated monocytes was deter-
mined in a multiwell chamber by adding 40,000
separated monocytes per well plus lymphocytes as
indicated.
b Lymphocytes were prepared from nonmigrating
cells recovered from the top well of a separation
chamber after chemotaxis. They were incubated for 2
h in Gey-BSA containing 50 ,ug of carrageenan per ml
to destroy monocytes. The cells were then washed
twice and counted. The monocyte contamination was
less than 2%. Lymphocytes incorporated [3H]thymi-
dine upon stimulation with B- or T-cell mitogens. Cells
were mixed, preincubated for 10 min, and then as-
sayed.
c Number of cells migrated per square millimeter of
filter ± standard error of the mean. N-Formylmethi-
onyl-leucyl-phenylalanine (FMLP) and C5a were used
at concentrations of 2 x 10-' M and 1:500, respective-
ly.
TABLE 3. Effect of a lymphocyte-nonmigrated
monocyte cell mixture on chemotaxis of purified
monocytesa
No. of Chemotactic response toc:
lymphocytes
per wellb Medium FNLP C5a
0 300 ± 30 1,950 ± 65 2,080 ± 105
5,000 150 ± 35 1,815 ± 90 1,900 ± 85
10,000 200 ± 25 1,850 + 180 1,850 ± 330
20,000 220 ± 25 1,490 ± 110 2,160 ± 320
40,000 295 ± 40 1,870 ± 260 2,120 ± 115
80,000 250 ± 20 2,110 ± 290 2,200 ± 230
a Migrating monocytes were separated by chemo-
taxis to CSa. The effect of the lymphocyte-nonmigrat-
ed monocyte cell mixture on the chemotactic response
of separated monocytes was determined in a multiwell
chamber by adding 40,000 separated monocytes per
well plus the lymphocyte-monocyte mixture as indi-
cated.
b A cell mixture consisting of nonmigrated mono-
cytes (25%) and lymphocytes (75%) was recovered
from the top well of a separation chamber after chemo-
taxis. Cells were mixed, preincubated for 10 min, and
then assayed.
c Number of cells migrated per square millimeter of
filter ± standard error of the mean. FNLP and CSa
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taxis chamber increased the number of macro-
phages that migrated (13).
In contrast, we reported previously that the
number of human monocytes migrating to che-
moattractant was proportional to the number of
input monocytes. Thus, the percentage of input
monocytes that migrated was independent of
cell density and remained constant over a wide
range of input cell numbers. In addition, over a
twofold range of lymphocyte numbers, mono-
cyte chemotaxis did not depend on the lympho-
cyte/monocyte ratio (8). This was also shown by
others using different methods (2, 19). The possi-
bility still remained that chemotaxis responsive-
ness of normal human monocytes is affected by
lymphocytes but that the number required is
smaller than the number present at the lowest
lymphocyte/monocyte ratio in previous experi-
ments. Also, Norris et al. showed that the
defective monocyte chemotaxis of patients with
mycosis fungoides was partially restored by
addition of lymphocytes from normal donors
(14).
We evaluated this point in studies on mono-
cytes purified in a chemotaxis separation cham-
ber, after which the cell suspension comprised
99% monocytes. Since only 20 to 60% of these
cells migrated to chemotaxins, we tested the
effect of adding various mononuclear cell prepa-
rations on chemotactic responsiveness. There
was no effect on the migration of the monocytes
(Tables 1-3). Thus, the capacity of human
monocytes from normal donors to migrate in a
chemotactic gradient does not appear to require
signals in vitro from enhancing or suppressing
cells.
Our studies suggest that one can distinguish
two distinct groups of mononuclear phagocytes
with respect to chemotactic responses: mono-
cyte type, characterized by no time lag before
migration toward attractant and no effect of cell
concentration on chemotactic response; and res-
ident peritoneal macrophage type, characterized
by a time lag before response to attractant
occurs and an increase in the percentage of cells
migrating when the input cell concentration is
increased. Human blood monocytes are in the
first category. Except for the time required for
settling of the cells, they were capable of an
immediate response to attractant, and the rate at
which the cells accumulated on the attractant
side of the filter was nearly constant until the
plateau was reached (Fig. 1 and 2). Also, chang-
ing the cell concentration did not change the
percentage of monocytes that migrated (Fig. 3).
Mouse blood monocytes are in this category in
that they exhibited no time lag in response to
attractant (5). The mouse monocyte-like cell line
WEHI-3 also behaved like the human blood
monocyte, exhibiting neither a time lag nor an
increased chemotactic response with increased
input cell concentration (1). In the resident peri-
toneal macrophage category are mouse resident
macrophages (13) and mouse macrophage-like
cell lines (1). They exhibit a time lag and require
a minimum critical cell concentration in the
upper well before they respond to attractant.
What accounts for the inability of some of the
migrated monocytes to respond again to che-
moattractant? In many respects, these cells are
normal. They all exclude trypan blue. Their
capacity to ingest immunoglobulin G-coated
erythrocytes is unimpaired (Falk and Leonard,
manuscript in preparation). Like unseparated
cells, their response to attractants begins with-
out a time lag (cf. Fig. 1 and 2). Thus, the
inability of a fraction of the migrated cells to
migrate again remains an enigma. Although a
formal explanation could be that there is a
requirement for an accessory cell and that the
ability to respond to this cell is lost in the
migrated population, there is no evidence that
would lead us to favor this possibility over any
other.
Our results showing no cell-cell interaction
with monocytes from normal subjects are in
contrast to the report that lymphocytes from
normal donors partially restore chemotactic re-
sponses of monocytes from patients with myco-
sis fungoides (14). It is possible that, at one stage
of their development, either in the bone marrow
or shortly after their release into the circulation,
monocytes require a stimulus by another cell to
differentiate into a chemotactically responsive
monocyte. The monocyte chemotaxis defects
that have been observed in disease may be due
to an impaired differentiating stimulus by anoth-
er cell type.
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